n-(3-(aminomethyl)benzyl)acetamidine has been researched along with aminolevulinic acid in 1 studies
*Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. [MeSH]
*Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fahey, JM; Girotti, AW | 1 |
1 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and aminolevulinic acid
| Article | Year |
|---|---|
Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors.
Topics: Amidines; Aminolevulinic Acid; Animals; Apoptosis; Apoptosis Regulatory Proteins; Benzoates; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Female; Heterografts; Humans; Imidazoles; Light; Mice, SCID; Neoplasm Invasiveness; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Sulfides; Up-Regulation | 2017 |